Literature DB >> 23817294

Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition.

A Simons1, L G Shaffer, R J Hastings.   

Abstract

The latest edition of the International System for Human Cytogenetic Nomenclature, ISCN 2013, has recently been published following a thorough revision of the 2009 issue and the incorporation of suggestions from the community by the current standing committee. This review will highlight the multiple nomenclature changes in the respective chapters of the 2013 version compared to the previous version of the ISCN published in 2009. These highlights are meant as a guide for the cytogeneticist to assist in the transition in the use of this updated nomenclature for describing cytogenetic and molecular cytogenetic findings in both clinical and research reports.

Entities:  

Mesh：

Year:  2013        PMID： 23817294     DOI： 10.1159/000353118

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN： 1424-8581            Impact factor:   1.636


  93 in total

1.  Microarray CGH analysis of hematological patients with del(20q).

Authors:  Chunxiao Wu; Jinlan Pan; Huiying Qiu; Yongquan Xue; Suning Chen; Yafang Wu; Jun zhang; Shuxiao Bai; Yong Wang; Juan Shen; Yanlei Gong
Journal:  Int J Hematol       Date:  2015-10-06       Impact factor: 2.490

2.  A rare case of three-way complex variant translocation in chronic myeloid leukemia t(6;9;22)(p21;q34;q11): A case report.

Authors:  Muhammad Asif; Abrar Hussain; Abdul Wali; Nazeer Ahmad; Naheed Sajjad; Muhammad Amir; Irfan Ali; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Biomed Rep       Date:  2017-08-17

3.  Precursor B cell lymphoid blast crisis of chronic myeloid leukemia with novel chromosomal abnormalities: A case report.

Authors:  Hamoud Al-Khallaf; Hani Alali; Adil Alkhatti
Journal:  Oncol Lett       Date:  2018-09-25       Impact factor: 2.967

4.  Myxoid liposarcoma with cartilaginous differentiation showing DDIT3 rearrangement.

Authors:  Kayo Suzuki; Taketoshi Yasuda; Kenta Watanabe; Takeshi Hori; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

5.  Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).

Authors:  Youfeng Yang; Cathy D Vocke; Christopher J Ricketts; Darmood Wei; Hesed M Padilla-Nash; Martin Lang; Carole Sourbier; J Keith Killian; Shawna L Boyle; Robert Worrell; Paul S Meltzer; Thomas Ried; Maria J Merino; Adam R Metwalli; W Marston Linehan
Journal:  Genes Chromosomes Cancer       Date:  2017-07-24       Impact factor: 5.006

6.  A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients.

Authors:  Yu-Hung Wang; Chien-Chin Lin; Chi-Yuan Yao; Chia-Lang Hsu; Hsin-An Hou; Cheng-Hong Tsai; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Blood Adv       Date:  2020-02-25

7.  A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.

Authors:  Anna Kalff; Tiffany Khong; Meaghan Wall; Malgorzata Gorniak; Sridurga Mithraprabhu; Lynda J Campbell; Andrew Spencer
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

8.  Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event.

Authors:  M Jawhar; J Schwaab; S Schnittger; K Sotlar; H-P Horny; G Metzgeroth; N Müller; S Schneider; N Naumann; C Walz; T Haferlach; P Valent; W-K Hofmann; N C P Cross; A Fabarius; A Reiter
Journal:  Leukemia       Date:  2015-01-08       Impact factor: 11.528

9.  Supporting interoperability of genetic data with LOINC.

Authors:  Jamalynne Deckard; Clement J McDonald; Daniel J Vreeman
Journal:  J Am Med Inform Assoc       Date:  2015-02-05       Impact factor: 4.497

10.  Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study.

Authors:  Bhavana Bhatnagar; Qiuhong Zhao; Alice S Mims; Sumithira Vasu; Gregory K Behbehani; Karilyn Larkin; James S Blachly; William Blum; Rebecca B Klisovic; Amy S Ruppert; Shelley Orwick; Christopher Oakes; Parvathi Ranganathan; John C Byrd; Alison R Walker; Ramiro Garzon
Journal:  Leuk Lymphoma       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.